{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:14:58Z","timestamp":1785838498225,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404677"],"award-info":[{"award-number":["82404677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["2021HXBH080"],"award-info":[{"award-number":["2021HXBH080"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clbc.2025.02.001","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:11:33Z","timestamp":1738843893000},"page":"e525-e532.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study"],"prefix":"10.1016","volume":"25","author":[{"given":"Xihan","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunxi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-7586","authenticated-orcid":false,"given":"Zongchao","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2025.02.001_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2025.02.001_bib0002","doi-asserted-by":"crossref","unstructured":"Lucci A., McCall L.M., Beitsch P.D., et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. 2016;25:3657-63. doi:10.1200\/JCO.2006.07.4062","DOI":"10.1200\/JCO.2006.07.4062"},{"key":"10.1016\/j.clbc.2025.02.001_bib0003","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1200\/JCO.2003.12.047","article-title":"Diminished survival in patients with inner versus outer quadrant breast cancers","volume":"21","author":"Gaffney","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2025.02.001_bib0005","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.clbc.2025.02.001_bib0006","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2025.02.001_bib0007","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","article-title":"Understanding breast cancer complexity to improve patient outcomes: the St Gallen International Consensus Conference for the Primary therapy of individuals with early breast cancer 2023","volume":"34","author":"Curigliano","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0009","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2025.02.001_bib0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2025.02.001_bib0011","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0012","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1245\/s10434-018-6429-2","article-title":"Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection?","volume":"25","author":"Moo","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0013","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1245\/s10434-021-09910-2","article-title":"Is residual nodal disease at axillary dissection associated with tumor subtype in patients with low volume sentinel node metastasis after neoadjuvant chemotherapy?","volume":"28","author":"Moo","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0014","first-page":"1","article-title":"Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the Surveillance, Epidemiology and End Results (SEER) database","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2025.02.001_bib0015","first-page":"1","article-title":"The extent of axillary surgery is associated with breast cancer-specific survival in T1-2 breast cancer patients with 1 or 2 positive lymph nodes","volume":"95","author":"Li","year":"2016","journal-title":"Med (United States)"},{"key":"10.1016\/j.clbc.2025.02.001_bib0016","series-title":"Breast Cancer (Version 2.2024)","year":"2024"},{"key":"10.1016\/j.clbc.2025.02.001_bib0017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-019-05500-9","article-title":"Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?","volume":"179","author":"LH","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2025.02.001_bib0018","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/0959-8049(92)90534-9","article-title":"Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG)","volume":"28A","author":"Axelsson","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2025.02.001_bib0019","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/1097-0142(19920515)69:10<2496::AID-CNCR2820691018>3.0.CO;2-T","article-title":"A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma","volume":"69","author":"Kiricuta","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2025.02.001_bib0020","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","article-title":"Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer","volume":"27","author":"Bilimoria","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12040950","article-title":"Validating the ACOSOG Z0011 trial result: a population-based study using the SEER database","volume":"12","author":"Jung","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2025.02.001_bib0022","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/annonc\/mdn746","article-title":"Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial","volume":"20","author":"Canavese","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0023","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1200\/JCO.2000.18.13.2553","article-title":"Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer","volume":"18","author":"Giuliano","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0024","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1245\/s10434-008-0195-5","article-title":"Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy","volume":"16","author":"Rescigno","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0025","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.34708","article-title":"Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?","volume":"129","author":"Lu","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2025.02.001_bib0026","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/bjs.10986","article-title":"Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer","volume":"105","author":"Tee","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2025.02.001_bib0027","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1245\/s10434-018-6637-9","article-title":"Decreasing use of axillary dissection in node-positive breast cancer patients treated with Neoadjuvant chemotherapy","volume":"25","author":"Nguyen","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0028","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1245\/s10434-020-08900-0","article-title":"Oncologic outcomes of Sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer","volume":"27","author":"Piltin","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2025.02.001_bib0029","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jamaoncol.2024.0578","article-title":"Omission of axillary dissection following nodal downstaging with Neoadjuvant chemotherapy","volume":"10","author":"Montagna","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","article-title":"Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment","volume":"42","author":"Galimberti","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0031","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","article-title":"Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy-A rare event","volume":"7","author":"Barrio","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0032","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","article-title":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","volume":"47","author":"Kahler-Ribeiro-Fontana","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2025.02.001_bib0033","doi-asserted-by":"crossref","first-page":"E544","DOI":"10.1097\/SLA.0000000000004562","article-title":"Sentinel node biopsy alone or with axillary dissection in breast cancer patients after primary chemotherapy: long-term results of a prospective interventional study","volume":"276","author":"Martelli","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2025.02.001_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jamcollsurg.2015.02.035","article-title":"Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer","volume":"221","author":"Yao","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clbc.2025.02.001_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.breast.2022.02.014","article-title":"Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis","volume":"63","author":"Gou","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2025.02.001_bib0036","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/bjs\/znac217","article-title":"Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey","volume":"109","author":"Gasparri","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2025.02.001_bib0037","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0002-9610(01)00719-X","article-title":"Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer","volume":"182","author":"Abdessalam","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.clbc.2025.02.001_bib0038","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","article-title":"A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy","volume":"10","author":"Van Zee","year":"2003","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:55:57Z","timestamp":1762548957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1526820925000308"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.02.001","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}